Cover About Us Financial Highlights To Our Shareholders Operational Effectiveness Innovating for Impact     Healthcare Worker Safety     Patient Safety     Diabetes     Infectious Diseases     HIV/AIDS     Immunization     Drug Discovery Social Responsibility and BD     Vaccine Grants/Johns Hopkins University     Project Perfect World     U.S. Fund for UNICEF / MNT Enterprise Profile Financials     Notes to Consolidated Financial Statements     Financial Review     Financial Statements Corporate Information Board of Directors Corporate Officers Back Cover

Financial highlights   Thousands of dollars, except per-share amounts   2004   2003   Change   Operating results Revenues $ 4,934,745   $ 4,463,509     10.6 % Income from continuing operations $ 582,504   $ 554,930     5.0 % Diluted earnings per share,       from continuing operations   2.21     2.10     5.2 % Dividends per common share      .60           .40           50.0 %